Poseida Therapeutics is a San Diego-based biotechnology company that is dedicated to developing innovative cell and gene therapies for life-threatening cancers and genetic diseases. With their cutting-edge genetic engineering technologies, including the non-viral piggyBac DNA Delivery System and the Cas-CLOVER Site-Specific Gene Editing System, Poseida Therapeutics aims to redefine treatment paradigms and provide new hope to patients.
By targeting specific cell populations, Poseida Therapeutics is able to advance fully allogeneic CAR-T therapies and develop functional cures for rare genetic diseases. Led by a team of experienced scientists and strategic leaders, the company is committed to revolutionizing the treatment of cancers and genetic diseases through transformative treatments.
Generated from the website